Nano-Scale Vascular Cleaning Robot Swarm VesselClean Deep Dive: Clearing Arterial Plaques to Avoid Stent Implantation

On December 18, 2029, Israeli nanomedicine company Nanomedic released the nano-scale vascular cleaning robot swarm VesselClean. These approximately 200-nanometer diameter micro-robots enter the vascular system through IV injection, using surface-modified targeting molecules to identify atherosclerotic plaques and clear them through mechanical grinding and enzymatic reactions.

VesselClean's core technology is a dual-positioning system of "magnetic navigation + targeted recognition." Each nanorobot's surface is coated with superparamagnetic iron oxide nanoparticles, allowing external magnetic field guidance to target vessel segments. Simultaneously, surface-modified antibodies specifically recognize oxidized low-density lipoprotein on plaque surfaces.

In porcine model experiments, VesselClean successfully reduced coronary artery stenosis from 70% to 15% without damaging normal vessel walls. This result is equivalent to reversing severe stenosis to mild, theoretically avoiding stent implantation surgery.

Nanomedic's CEO said approximately 4 million coronary stent implantations occur globally each year, a significant portion of which could be replaced by non-surgical approaches like VesselClean. The company plans to initiate Phase I clinical trials in 2030, initially targeting peripheral artery disease.